1 Day
Source:
The Fiscal Times
_1777370220974_847775619.png&w=48&q=75){kind=small}
Flu vaccine mFlusiva approved for seniors
The FDA has approved Moderna’s new mRNA-based flu vaccine, mFlusiva, for adults aged 50 and older. The vaccine received full approval for those aged 50-64 and accelerated approval for seniors aged 65 and older, with data showing it is safe and effective. This development introduces a new flu shot option using innovative technology, which may improve response to evolving flu strains.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)